Intrasense, specialist in medical imaging software solutions and creator of Myrian®, and Guerbet, world leader in medical imaging, announce that the Myrian® 2.12 platform has obtained CE certification under MDR1, integrating the prostate AI developed by Guerbet, the Veolity® LungCAD AI developed by Mevis and the
Icobrain AI developed by Icometrix.

' This market launch is a major step in the joint development plan of both companies and the realization of their growth ambitions ' says management.

' The certification of our Myrian® 2.12 solution represents a crucial step in our innovation trajectory. This validation marks our ongoing commitment to technological excellence and also represents an
opportunity to accelerate our growth. The new AI algorithms, developed in particular by our partner Guerbet, will enable us to
reinforce the added value of our software solutions and maximize the relevance of our offering in the marketplace," says Nicolas Reymond, Intrasense CEO.

Copyright (c) 2024 CercleFinance.com. All rights reserved.